Neurocognitive functions in euthymic bipolar patients

Acta Psychiatrica Scandinavica

Volumn 119, Issue 5, 2009, Pages 365-374

  Jamrozinski, K ^a   Gruber, O ^a   Kemmer, C ^b   Falkai, P ^a   Scherk, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Antipsychotics; Bipolar disorder; Cognition; Neuropsychology

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION; BIPOLAR I DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LEARNING; MALE; MEMORY; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; VERBAL BEHAVIOR;

ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; ATTENTION; BIPOLAR DISORDER; BRAIN; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEARNING; LITHIUM CARBONATE; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; SEMANTICS; VERBAL BEHAVIOR;

EID: 64349106057     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2008.01320.x     Document Type: Article

References (67)

1. Cavanagh JT, Van Beck M, Muir W, Blackwood DH. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002 180 : 320 326.
2. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002 180 : 313 319.
3. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999 175 : 246 251.
4. Martínez-Arán A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004 161 : 262 270.
5. Martínez-Arán A, Vieta E, Colom F et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004 6 : 224 232.
6. Rubinsztein JS, Michael A, Paykel ES, Sahakian BJ. Cognitive impairment in remission in bipolar affective disorder. Psychol Med 2000 30 : 1025 1036.
7. Smith DJ, Muir WJ, Blackwood DH. Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder. Bipolar Disord 2006 8 : 40 46.
8. Thompson JM, Gallagher P, Hughes JH et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005 186 : 32 40.
9. Ferrier IN, Chowdhury R, Thompson JM, Watson S, Young AH. Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: a preliminary report. Bipolar Disord 2004 6 : 319 322.
10. McIntosh AM, Harrison LK, Forrester K, Lawrie SM, Johnstone EC. Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. Br J Psychiatry 2005 186 : 378 385.
11. Sobczak S, Honig A, Nicolson NA, Riedel WJ. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls. Neuropsychopharmacology 2002 27 : 834 842.
12. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001 3 : 106 150.
13. Daban C, Martinez-Aran A, Torrent C et al. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother Psychosom 2006 75 : 72 84.
14. Engelsmann F, Katz J, Ghadirian AM, Schachter D. Lithium and memory: a long-term follow-up study. J Clin Psychopharmacol 1988 8 : 207 212.
15. Kocsis JH, Shaw ED, Stokes PE et al. Neuropsychologic effects of lithium discontinuation. J Clin Psychopharmacol 1993 13 : 268 275.
16. Squire LR, Judd LL, Janowsky DS, Huey LY. Effects of lithium carbonate on memory and other cognitive functions. Am J Psychiatry 1980 137 : 1042 1046.
17. Amado-Boccara I, Gougoulis N, Poirier Littré MF, Galinowski A, Lôo H. Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 1995 19 : 479 493.
18. Thompson PJ. Antidepressants and memory: a review. Hum Psychopharmacol 1991 6 : 79 90.
19. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995 36 (suppl. 2 S46 S65.
20. Kaye NS, Graham J, Roberts J, Thompson T, Nanry K. Effect of open-label lamotrigine as monotherapy and adjunctive therapy on the self-assessed cognitive function scores of patients with bipolar I disorder. J Clin Psychopharmacol 2007 27 : 387 391.
21. Bilder RM, Goldman RS, Volavka J et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002 159 : 1018 1028.
22. Cassens G, Inglis AK, Appelbaum PS, Gutheil TG. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr Bull 1990 16 : 477 499.
23. King DJ. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990 157 : 799 811.
24. King DJ. Psychomotor impairment and cognitive disturbances induced by neuroleptics. Acta Psychiatr Scand Suppl 1994 380 : 53 58.
25. Morrens M, Wezenberg E, Verkes RJ, Hulstijn W, Ruigt GS, Sabbe BG. Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration. J Clin Psychopharmacol 2007 27 : 15 21.
26. Beracochea D. Anterograde and retrograde effects of benzodiazepines on memory. Scientific World Journal 2006 6 : 1460 1465.
27. Maruff P, Werth J, Giordani B, Caveney AF, Feltner D, Snyder PJ. A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam. Psychopharmacology (Berl) 2006 186 : 7 17.
28. Snyder PJ, Werth J, Giordani B, Caveney AF, Feltner D, Maruff P. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. Hum Psychopharmacol 2005 20 : 263 273.
29. Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord 2007 9 : 93 102.
30. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. Strukturiertes klinisches interview für DSM-IV, achse I (SKID). Göttingen : Hogrefe, 1997.
31. Fydrich T, Renneberg B, Schmitz B, Wittchen HU. Strukturiertes klinisches interview für DSM-IV-achse II: persönlichkeitsstörungen. Göttingen, Bern : Hogrefe, 1997.
32. Davis JM. Dose equivalence of the antipsychotic drugs. J Psychiatr Res 1974 11 : 65 69.
33. First MB, Spitzer RL, Gibbon M et al. The structured clinical interview for DSM-III-R personality disorders (SCID-II). J Personal Disord 1995 9 : 92 104.
34. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978 133 : 429 435.
35. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 : 382 389.
36. Schmidt KH, Metzler P. Wortschatztest WST. Weinheim : Beltz, 1992.
37. Aschenbrenner S, Tucha O, Lange KW. Regensburger wortflü ssigkeitstest. Göttingen : Hogrefe, 2000.
38. Helmstaedter C, Lendt M, Lux S. VLMT verbaler lern und merkfähigkeitstest. Test und testhandbuch. Göttingen : Beltz Test GmbH, 2001.
39. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin card sorting test manual - revised and expanded. Lutz, FL : PAR, 1993.
40. Shallice T. Specific impairments in planning. Philos Trans R Soc Lond B Biol Sci 1982 298 : 199 209.
41. Zimmermann P, Fimm B. Testbatterie zur aufmerksamkeitsprüfung (TAP). Version 1.02c: Handbuch. Würselen : Psytest, 1993.
42. Oswald WD, Roth E. Der Zahlen-Verbindungs-Test (ZVT): Handanweisung (2 Aufl.). Göttingen : Hogrefe, 1987.
43. Martínez-Arán A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007 9 : 103 113.
44. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002 72 : 209 226.
45. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006 93 : 105 115.
46. Hughes AM, Lynch P, Rhodes J, Ervine CM, Yates RA. Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers. Br J Clin Pharmacol 1999 48 : 323 330.
47. Ramaekers JG, Louwerens JW, Muntjewerff ND et al. Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic. J Clin Psychopharmacol 1999 19 : 209 221.
48. Peters UH. Wörterbuch der psychiatrie und medizinischen psychologie. Augsburg : Bechtermünz Verlag, 1997.
49. Cuesta MJ, Peralta V, Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 2001 48 : 17 28.
50. Keefe RS, Sweeney JA, Gu H et al. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 2007 164 : 1061 1071.
51. Lee SM, Chou YH, Li MH, Wan FJ, Yen MH. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 2007 31 : 1101 1107.
52. Arnsten AFT. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cognit Sci 1998 2 : 436 446.
53. Cools R, Robbins TW. Chemistry of the adaptive mind. Philos Transact A Math Phys Eng Sci 2004 362 : 2871 2888.
54. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Mausley bipolar disorder project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003 64 : 86 93.
55. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein L. The Maudsley bipolar disorder project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry 2005 58 : 859 864.
56. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007 64 : 442 455.
57. Taylor MJ, Goodwin GM. Long-term prophylaxis in bipolar disorder. CNS Drugs 2006 20 : 303 310.
58. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990 47 : 1106 1111.
59. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004 6 : 171 182.
60. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006 60 : 93 105.
61. Savitz JB, Solms M, Ramesar RS. Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder. Neuromolecular Med 2005 7 : 275 286.
62. Savitz JB, Solms M, Ramesar RS. Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord 2005 7 : 216 235.
63. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2007 9 : 1 15 [Epub ahead of print].
64. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord. 2007 9 : 114 125.
65. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007 434 : 17 26.
66. Dittmann S, Seemüller F, Schwarz MJ et al. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord 2007 9 : 63 70.
67. Dittmann S, Seemüller F, Grunze HC et al. The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. J Clin Psychiatry 2008 69 : 899 906.